Premium
Regulatory Frameworks in Times of Uncertainty
Author(s) -
Breckenridge Alasdair
Publication year - 2019
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1002/cpt.1122
Subject(s) - authorization , regulatory science , regulator , marketing authorization , business , risk analysis (engineering) , medicine , computer science , computer security , bioinformatics , biology , pathology , biochemistry , gene
Patient and public expectations on access to new types of medicines has changed the role of the regulator in granting marketing authorizations. Whether current regulatory frameworks can accommodate further advances in biomedical science remains a challenge, but suggestions are made as to how this may be possible.